ADVERTISEMENT

BioNTech

EU authorises use of adapted Pfizer/BioNtech vaccine for Covid-19 variant

The European Medicines Authority (EMA) and the European Centre for Disease Prevention and Control recommend a single dose irrespective of vaccination history.

01 September 2023, 09:02 IST

EU authorises use of adapted Pfizer/BioNtech vaccine for Covid-19 variant

EU authorises use of adapted Pfizer/BioNtech vaccine for Covid-19 variant

EU authorises use of adapted Pfizer/BioNtech vaccine for Covid-19 variant

01 September 2023, 09:02 IST

BioNTech reduces drug development spend as Covid shot sales plunge

Second-quarter revenue dropped to €167.7 million ($184 million) from €3.2 billion a year earlier, as write-offs on Pfizer's assets ate into profit share payments.

07 August 2023, 14:08 IST

BioNTech reduces drug development spend as Covid shot sales plunge

BioNTech reduces drug development spend as Covid shot sales plunge

BioNTech reduces drug development spend as Covid shot sales plunge

07 August 2023, 14:08 IST

BioNTech ships 11,500 doses of Covid vaccine to China

The vaccines are expected to be available in Beijing, Shanghai, Guangzhou, Shenyang and Chengdu, BioNTech said

22 December 2022, 13:16 IST

BioNTech ships 11,500 doses of Covid-19 vaccine to China

BioNTech ships 11,500 doses of Covid-19 vaccine to China

BioNTech ships 11,500 doses of Covid vaccine to China

22 December 2022, 13:16 IST

Pfizer-BioNTech to test combined Covid-influenza jab

The combined vaccine is set to begin trials in the United States

03 November 2022, 14:36 IST

Pfizer-BioNTech to test combined Covid-19, influenza vaccine

Pfizer-BioNTech to test combined Covid-19, influenza vaccine

Pfizer-BioNTech to test combined Covid-influenza jab

03 November 2022, 14:36 IST

BioNTech develops method to detect high-risk variants

BioNTech and its partner said the new computational method can analyse genetic sequencing data of new coronavirus mutations

11 January 2022, 13:50 IST

BioNTech develops method to detect high-risk variants

BioNTech develops method to detect high-risk variants

BioNTech develops method to detect high-risk variants

11 January 2022, 13:50 IST

Pfizer and BioNTech to develop mRNA-based shingles jab

05 January 2022, 15:21 IST

Pfizer and BioNTech to develop mRNA-based shingles jab

Pfizer and BioNTech to develop mRNA-based shingles jab

Pfizer and BioNTech to develop mRNA-based shingles jab

05 January 2022, 15:21 IST

Possible to adapt jab quickly for Omicron: BioNTech CEO

Sahin also said that vaccines should continue to provide protection against severe disease, despite mutations

03 December 2021, 13:51 IST

BioNTech CEO says possible to adapt vaccine quickly for Omicron

BioNTech CEO says possible to adapt vaccine quickly for Omicron

Possible to adapt jab quickly for Omicron: BioNTech CEO

03 December 2021, 13:51 IST

Research finds Covid infection risk rises after second vaccine dose

29 November 2021, 06:18 IST

fallback

fallback

Research finds Covid infection risk rises after second vaccine dose

29 November 2021, 06:18 IST

BioNTech to seek approval for vaccine for 5-11-yr-olds

It has also laid out plans to seek approval in children aged 6 months to 2 years later this year

10 September 2021, 11:09 IST

BioNTech to seek approval soon for vaccine for 5-11-year-olds

BioNTech to seek approval soon for vaccine for 5-11-year-olds

BioNTech to seek approval for vaccine for 5-11-yr-olds

10 September 2021, 11:09 IST

BioNTech eye Rwanda, Senegal for malaria jab production

The future malaria and tuberculosis vaccines would be based on the so-called messenger RNA technology

27 August 2021, 14:51 IST

BioNTech eye Rwanda, Senegal for malaria, tuberculosis vaccine production

BioNTech eye Rwanda, Senegal for malaria, tuberculosis vaccine production

BioNTech eye Rwanda, Senegal for malaria jab production

27 August 2021, 14:51 IST